GlassScriptPhysician profile
Cary A Harbater
NPI 1811347636
$1,863.07
in general payments reported to CMS, 2019-2025
21 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $360 · 2023: $357 · 2024: $437 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $561.33 | 2021-2024 | |
| Scilex Pharmaceuticals INC. | $241.86 | 2021-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $230.12 | 2021-2024 | Belbuca, Xtampza |
| Pfizer INC. | $191.49 | 2021-2024 | |
| Genmab U.S., INC. | $125.00 | 2025 | Epkinly |
| Pharmaessentia USA Corporation | $110.12 | 2025 | Besremi |
| Biohaven Pharmaceutical Holding Company LTD. | $96.30 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.26 | 2021-2023 | Relistor |
| Protega Pharmaceutials INC | $38.75 | 2024 | Roxybond |
| Biodelivery Sciences International, INC. | $30.33 | 2021 | |
| Novo Nordisk INC | $29.31 | 2022 | |
| Idorsia Pharmaceuticals US INC | $22.93 | 2022 | |
| Lilly USA, LLC | $19.32 | 2021 | |
| Deciphera Pharmaceuticals INC. | $18.14 | 2025 | Qinlock, Romvimza |
| Legend Biotech USA INC. | $17.68 | 2025 | Carvykti |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $17.39 | 2021 | |
| Uswm, LLC | $15.82 | 2021 | |
| Lundbeck LLC | $15.67 | 2022 | |
| Amgen INC. | $14.89 | 2022 | |
| Virtus Pharmaceuticals LLC | $13.42 | 2021 | |
| Indivior INC. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cary Harbater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.